Clinical commissioning policy: Osilodrostat phosphate for adult patients with endogenous Cushing’s syndrome

Document first published:
Page updated:
Topic:
Publication type:

Osilodrostat phosphate is not recommended to be available as a routinely commissioned treatment for adult patients with endogenous Cushing’s Syndrome.

Document

Clinical commissioning policy: Osilodrostat phosphate for adult patients with endogenous Cushing’s syndrome

Clinical commissioning policy: Osilodrostat phosphate for adult patients with endogenous Cushing’s syndrome

  • PDF
  • 136 KB
  • 5 pages

Summary

Published 16 July 2026.